Radiopharm Theranostics Ltd.

Industry

  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Large Molecule
      • Antibodies
See more in Biomedtracker

Latest on Radiopharm Theranostics Ltd.

Scrip

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

Scrip

Asia Deal Watch: ProGen To Partner With Rani On GLP-2 Agonist In Obesity

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. ProGen Partners With Rani To Devel

Scrip

Deal Watch: Adaptimmune, TCR2 Join Forces As Cell Therapy Company Focused On Solid Tumors

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Adaptimmune, TCR² Combine Forces, Incre

Scrip

Tech Transfer Roundup: MD Anderson, NCI Lead Cancer Alliances

 
• By Joseph Haas

The pace of cancer partnering between the biopharma industry and academic and institutional research entities during the final months of 2022 remained typically brisk, and two US institutions – The U